DrugPatentWatch Database Preview
Altaire Pharms Inc Company Profile
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
What is the competitive landscape for ALTAIRE PHARMS INC, and what generic and branded alternatives to ALTAIRE PHARMS INC drugs are available?
ALTAIRE PHARMS INC has five approved drugs.
Summary for Altaire Pharms Inc
| US Patents: | 0 |
| Tradenames: | 5 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Altaire Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Altaire Pharms Inc | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 078208-001 | Sep 27, 2010 | OTC | No | No | Start Trial | Start Trial | |||||
| Altaire Pharms Inc | CIPROFLOXACIN HYDROCHLORIDE | ciprofloxacin hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 204613-001 | May 3, 2018 | AT | RX | No | No | Start Trial | Start Trial | ||||
| Altaire Pharms Inc | OFLOXACIN | ofloxacin | SOLUTION/DROPS;OPHTHALMIC | 202692-001 | Apr 29, 2013 | AT | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
